Royal Bank of Canada’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51K | Sell |
44,632
-318,070
| -88% | -$363K | ﹤0.01% | 5546 |
|
|
2025
Q1 | $491K | Buy |
362,702
+250,185
| +222% | +$339K | ﹤0.01% | 3687 |
|
|
2024
Q4 | $1.48M | Buy |
112,517
+6,947
| +7% | +$91.5K | ﹤0.01% | 2849 |
|
|
2024
Q3 | $1.18M | Buy |
105,570
+53,530
| +103% | +$600K | ﹤0.01% | 3026 |
|
|
2024
Q2 | $560K | Buy |
52,040
+4,734
| +10% | +$50.9K | ﹤0.01% | 3573 |
|
|
2024
Q1 | $704K | Sell |
47,306
-18,581
| -28% | -$277K | ﹤0.01% | 3345 |
|
|
2023
Q4 | $1.19M | Buy |
65,887
+13,436
| +26% | +$243K | ﹤0.01% | 3055 |
|
|
2023
Q3 | $910K | Buy |
52,451
+13,155
| +33% | +$228K | ﹤0.01% | 3079 |
|
|
2023
Q2 | $712K | Sell |
39,296
-21,329
| -35% | -$386K | ﹤0.01% | 3278 |
|
|
2023
Q1 | $1.61M | Buy |
60,625
+38,466
| +174% | +$1.02M | ﹤0.01% | 2660 |
|
|
2022
Q4 | $428K | Buy |
22,159
+2,339
| +12% | +$45.2K | ﹤0.01% | 3804 |
|
|
2022
Q3 | $415K | Buy |
19,820
+19,551
| +7,268% | +$409K | ﹤0.01% | 3724 |
|
|
2022
Q2 | $2K | Sell |
269
-1,396
| -84% | -$10.4K | ﹤0.01% | 6515 |
|
|
2022
Q1 | $11K | Sell |
1,665
-3,630
| -69% | -$24K | ﹤0.01% | 6423 |
|
|
2021
Q4 | $71K | Buy |
5,295
+2,905
| +122% | +$39K | ﹤0.01% | 5641 |
|
|
2021
Q3 | $40K | Buy |
2,390
+743
| +45% | +$12.4K | ﹤0.01% | 5771 |
|
|
2021
Q2 | $48K | Sell |
1,647
-481
| -23% | -$14K | ﹤0.01% | 5579 |
|
|
2021
Q1 | $84K | Buy |
2,128
+1,899
| +829% | +$75K | ﹤0.01% | 5089 |
|
|
2020
Q4 | $5K | Buy |
+229
| New | +$5K | ﹤0.01% | 6090 |
|